Clinical Trials Browser

Completed × INDUSTRY × Biological Products × Clear all

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Phase 1/2 Completed

High Grade Cervical Intraepithelial Neoplasia

NCT04436133 2022-05-06

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Phase 2 Completed

Papillomavirus Infections